Skip to content

Solid Biosciences Inc. SLDB Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-57.4%+52.5pp-109.9%-23.1pp-86.8%-18.6pp-68.2%-13.0pp-55.3%+39.3pp
Return on invested capital-191.5%-30.4pp-161.1%-50.2pp-111%+7.4pp-118.3%+7.9pp-126.2%+36.0pp
Liquidity
Current ratio13.1×+7.0×6.1×-0.6×6.7×-2.6×9.3×-1.6×10.9×+5.7×
Leverage
Debt-to-equity0.1×-0.1×0.1×0.0×0.1×0.0×0.1×0.0×0.1×-0.1×
Per Share
Book value per share$3.41+65.6%$2.06-10.9%$2.31-15.9%$2.74-38.2%$4.44+32.0%
Valuation
Market capitalization$910.66M+145%$439.41M-8.5%$480.45M+27.7%$376.34M+31.3%$286.72M+79.4%
Price / book2.4×+1.2×2.4×+0.2×2.2×+0.7×1.5×+0.5×-0.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Solid Biosciences Inc.'s ratios come from?
Every ratio is computed from Solid Biosciences Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.